HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana

被引:2
作者
Kelentse, Nametso [1 ,2 ]
Moyo, Sikhulile [1 ,3 ]
Mogwele, Mompati L. [1 ,4 ]
Ditshwanelo, Doreen [1 ]
Mokaleng, Baitshepi [1 ,2 ]
Moraka, Natasha O. [1 ,5 ]
Lechiile, Kwana [1 ,6 ]
Leeme, Tshepo B. [1 ,6 ]
Lawrence, David S. [1 ,7 ]
Musonda, Rosemary [1 ,3 ]
Kasvosve, Ishmael [2 ]
Harrison, Thomas S. [8 ]
Jarvis, Joseph N. [1 ,6 ,7 ,9 ]
Gaseitsiwe, Simani [1 ,3 ]
机构
[1] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana
[2] Univ Botswana, Fac Hlth Sci, Sch Allied Hlth Profess, Gaborone, Botswana
[3] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[4] Univ Botswana, Dept Biol Sci, Gaborone, Botswana
[5] Stellenbosch Univ, Dept Pathol, ZA-7505 Stellenbosch, South Africa
[6] Botswana Univ Pennsylvania Partnership, Gaborone, Botswana
[7] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1E 7HT, England
[8] St Georges Univ London, Inst Infect & Immun, Ctr Global Hlth, London SW17 0RE, England
[9] Univ Penn, Perelman Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA
来源
VIRUSES-BASEL | 2020年 / 12卷 / 12期
基金
英国惠康基金;
关键词
Botswana; CCR5; CXCR4; cerebrospinal fluid; co-receptor; cryptococcal meningitis; escape mutations; human immunodeficiency virus (HIV); plasma; LINKED GLYCOSYLATION SITE; ANTIRETROVIRAL THERAPY; GLYCAN SHIELD; ESCAPE; TROPISM; RESERVOIRS; MUTATIONS; INDIVIDUALS; PERFORMANCE; ALGORITHMS;
D O I
10.3390/v12121404
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 compartmentalization in reservoir sites remains a barrier to complete HIV eradication. It is unclear whether there is variation in HIV-1 env and gag between cerebrospinal fluid (CSF) and plasma of individuals with HIV-associated cryptococcal meningitis (CM). We compared HIV-1 env characteristics and the gag cytotoxic T-lymphocyte (CTL) escape mutations from CSF and plasma samples. Employing population-based Sanger sequencing, we sequenced HIV-1 env from CSF of 25 patients and plasma of 26 patients. For gag, 15 CSF and 21 plasma samples were successfully sequenced. Of these, 18 and 9 were paired env and gag CSF/plasma samples, respectively. There was no statistically significant difference in the proportion of CCR5-using strains in the CSF and plasma, (p = 0.50). Discordant CSF/plasma virus co-receptor use was found in 2/18 pairs (11.1%). The polymorphisms in the HIV-1 V3 loop were concordant between the two compartments. From the HIV-1 gag sequences, three pairs had discordant CTL escape mutations in three different epitopes of the nine analyzed. These findings suggest little variation in the HIV-1 env between plasma and CSF and that the CCR5-using strains predominate in both compartments. HIV-1 gag CTL escape mutations also displayed little variation in CSF and plasma suggesting similar CTL selective pressure.
引用
收藏
页数:17
相关论文
共 51 条
[41]   Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides [J].
Seipone, Ikanyeng D. ;
Singh, Ravesh ;
Patel, Vinod B. ;
Singh, Avashna ;
Gordon, Michelle L. ;
Muema, Daniel M. ;
Dheda, Keertan ;
Ndung'u, Thumbi .
PLOS ONE, 2018, 13 (02)
[42]  
Sojane K, 2018, AIDS RES HUM RETROV, V34, P607, DOI [10.1089/aid.2017.0209, 10.1089/AID.2017.0209]
[43]   Presence of HIV-1 R5 Viruses in Cerebrospinal Fluid Even in Patients Harboring R5X4/X4 Viruses in Plasma [J].
Soulie, Cathia ;
Tubiana, Roland ;
Simon, Anne ;
Lambert-Niclot, Sidonie ;
Malet, Isabelle ;
Canestri, Ana ;
Brunet, Christel ;
Murphy, Robert ;
Katlama, Christine ;
Calvez, Vincent ;
Marcelin, Anne-Genevieve .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (01) :60-64
[44]   COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification [J].
Struck, Daniel ;
Lawyer, Glenn ;
Ternes, Anne-Marie ;
Schmit, Jean-Claude ;
Bercoff, Danielle Perez .
NUCLEIC ACIDS RESEARCH, 2014, 42 (18)
[45]   Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection [J].
Sturdevant, Christa Buckheit ;
Joseph, Sarah B. ;
Schnell, Gretja ;
Price, Richard W. ;
Swanstrom, Ronald ;
Spudich, Serena .
PLOS PATHOGENS, 2015, 11 (03) :1-24
[46]  
Travers Simon A, 2012, ISRN AIDS, V2012, P823605, DOI 10.5402/2012/823605
[47]   Hiv-1 tropism testing and clinical management of CCr5 antagonists: Quebec review and recommendations [J].
Tremblay, Cecile ;
Hardy, Isabelle ;
Lalonde, Richard ;
Trottier, Benoit ;
Tsarevsky, Irina ;
Vezina, Louis-Philippe ;
Roger, Michel ;
Wainberg, Mark ;
Baril, Jean-Guy .
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2013, 24 (04) :202-208
[48]  
Vazquez-Santiago Fabian, 2015, J Virol Antivir Res, V4, DOI 10.4172/2324-8955.1000135
[49]   Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility [J].
Walter, Brandon L. ;
Armitage, Andrew E. ;
Graham, Stephen C. ;
de Oliveira, Tulio ;
Skinhoj, Peter ;
Jones, E. Yvonne ;
Stuart, David I. ;
McMichael, Andrew J. ;
Chesebro, Bruce ;
Iversen, Astrid K. N. .
AIDS, 2009, 23 (09) :1047-1057
[50]   Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry [J].
Westby, Mike ;
Smith-Burchnell, Caroline ;
Mori, Julie ;
Lewis, Marilyn ;
Mosley, Michael ;
Stockdale, Mark ;
Dorr, Patrick ;
Ciaramella, Giuseppe ;
Perros, Manos .
JOURNAL OF VIROLOGY, 2007, 81 (05) :2359-2371